Recombinant tissue-plasminogen adivator-induced thrombolysis after cerebral thromboembolism in mice

Acta Neuropathologica

Volumn 99, Issue 3, 2000, Pages 219-222

  Kilic, Ertugrul ^a   Hermann, Dirk M ^a   Hossmann, Konstantin Alexander ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

Focal ischemia; Middle cerebral artery occlusion; Mouse; Thromboembolism; Thrombolysis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN INFARCTION; CAROTID ARTERY; LASER DOPPLER FLOWMETRY; MALE; MIDDLE CEREBRAL ARTERY; MOUSE; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; STAINING;

EID: 0033953958     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007430     Document Type: Article

References (15)

1. Busch E, Krüger K, Hossmann K-A (1998) Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat. Brain Res 778: 16-24
2. Busch E, Krüger K, Allegrini PR, Kerskens CM, Gyngell ML, Hoehn-Berlage M, Hossmann K-A (1998) Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging. J Cereb Blood Flow Metab 18: 407-418
3. Fink K, Zhu J, Namura S, Shimizu-Sasamata M, Endres M, Ma J, Dalkara T, Yuan J, Moskowitz MA (1998) Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation. J Cereb Blood Flow Metab 18: 1071-1076
4. Furlan AJ, Kanoti G (1997) When is thrombolysis justified in patients with acute ischemic stroke? A bioethical perspective. Stroke 28: 214-218
5. Hata R, Mies G, Wiessner C, Fritze K, Hesselbarth D, Brinker G, Hossmann K-A (1998) A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging. J Cereb Blood Flow Metab 18: 367-375
6. Kaplan B, Brint S, Tanabe J, Jacewicz M, Wang XJ, Pulsinelli W (1991) Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia. Stroke 22: 1032-1039
7. Karges HE, Funk KA, Ronneberg H (1994) Activity of coagulation and fibrinolysis parameters in animals. Drug Res 44: 793-797
8. Kilic E, Hermann DM, Hossmann K-A (1998) A reproducible model of thromboembolic stroke in mice. Neuroreport 9: 2967-2970
9. Korninger C, Collen D (1981) Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro. Thromb Haemost 46: 561-565
10. Munkvad S, Jespersen J, Gram J, Kluft C (1990) Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endothelium. J Intern Med 228: 361-366
11. Overgaard K (1994) Thrombolytic therapy in experimental embolic stroke. Cerebrovasc Brain Metab Rev 6: 257-286
12. Overgaard K, Sereghy T, Boysen G, Pedersen H, Hoyer S, Diemer NH (1992) A rat model of reproducible cerebral infarction using thrombotic blood clot emboli. J Cereb Blood Flow Metab 12: 484-490
13. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10: 290-293
14. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581-1587
15. Verstraete M, Bounameaux H, Cock F de, Werf F van de, Collen D (1985) Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans. J Pharmacol Exp Ther 235: 506-512